TREA

88788969 - ALKERMES

Follow

Information

  • Trademark
  • 88788969
  • Serial Number
    88788969
  • Registration Number
    6925355
  • Filing Date
    February 07, 2020
    5 years ago
  • Registration Date
    December 13, 2022
    2 years ago
  • Transaction Date
    December 13, 2022
    2 years ago
  • Status Date
    December 13, 2022
    2 years ago
  • Published for Opposition Date
    September 22, 2020
    4 years ago
  • Location Date
    November 08, 2022
    2 years ago
  • First Use Anywhere Date
    January 21, 2022
    3 years ago
  • First Use In Commerce Date
    January 21, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DANG, PETER T
  • Attorney Docket Number
    029318-2824
    Attorney Name
    Norm J. Rich
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ALKERMES
Case File Statements
  • GS0051: Pharmaceutical preparations, namely, compounds for use in treating addiction, substance abuse and dependence, diseases and disorders of the central nervous system, cancer, reward disorders, psychiatric and neurodegenerative diseases and disorders in the nature of schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, and bipolar disorder; pharmaceutical preparations for use in treating cardiovascular diseases and metabolic diseases; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidaemia; Pharmaceutical preparations, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; pharmaceutical preparations in the nature of compounds, namely, small molecules and chemical compounds for use in opioid modulation for treating opioid use disorders
  • GS0361: Providing grants to organizations dedicated to patient focused medical research; funding service awards, namely, providing grants to patient advocacy groups and institutions for the treatment and management of diseases including, but not limited to, addiction and central nervous system disorders; Providing insurance information about pharmacies, namely, providing a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing insurance information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services, namely, insurance eligibility review and verification being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment in the health industry; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs
  • GS0351: Administration and management of an annual competitive award program in the nature of research grants for scientific research; Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about processing online prescription orders in retail pharmacies regarding pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients
  • GS0451: Support services for health care providers and their patients in the nature of providing patient advocate and case management services, namely, coordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and/or administer prescribed medication
  • GS0441: Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about pharmaceutical products relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Case File Event Statements
  • 12/13/2022 - 2 years ago
    37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/9/2022 - 2 years ago
    36 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 11/8/2022 - 2 years ago
    35 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 11/8/2022 - 2 years ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/7/2022 - 2 years ago
    33 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 10/28/2022 - 2 years ago
    32 - USE AMENDMENT FILED Type: IUAF
  • 11/7/2022 - 2 years ago
    31 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 10/28/2022 - 2 years ago
    30 - SOU EXTENSION 4 FILED Type: EXT4
  • 11/7/2022 - 2 years ago
    29 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 10/28/2022 - 2 years ago
    28 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/28/2022 - 2 years ago
    27 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/7/2022 - 2 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/5/2022 - 2 years ago
    25 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 5/5/2022 - 2 years ago
    24 - SOU EXTENSION 3 FILED Type: EXT3
  • 5/5/2022 - 2 years ago
    23 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/18/2021 - 3 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/16/2021 - 3 years ago
    21 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 11/16/2021 - 3 years ago
    20 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/16/2021 - 3 years ago
    19 - TEAS EXTENSION RECEIVED Type: EEXT
  • 5/1/2021 - 3 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/29/2021 - 3 years ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/29/2021 - 3 years ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/29/2021 - 3 years ago
    15 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/17/2020 - 4 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/22/2020 - 4 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/22/2020 - 4 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/2/2020 - 4 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/17/2020 - 4 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/7/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/6/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/6/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/28/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/28/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/28/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/28/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/11/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/11/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP